Navigation Links
Columbus Included in Analysis of Top Hypertension Hot Spots in the United States

DEERFIELD, Ill., Aug. 18, 2011 /PRNewswire/ -- A national analysis conducted by Sperling's BestPlaces and sponsored by Takeda Pharmaceuticals North America, Inc., identified Columbus, Ohio, as one of the nation's Hypertension Hot Spots, or cities that have hypertension risk factors and complications. The identification of the Hypertension Hot Spots is part of a larger Takeda-sponsored hypertension awareness program called Commit to Control, which educates Americans about hypertension and also challenges patients to do all they can to get their blood pressure under control.

Columbus ranked 16th on the list of 50 U.S. metropolitan areas that have hypertension risk factors and complications. Furthermore, in 2009, nearly one-third of people in the state of Ohio had been informed they have high blood pressure, according to the Centers for Disease Control and Prevention. The large-scale Hot Spots analysis, which combined findings of original research and existing, related research in the field of the study, analyzed data about numerous hypertension risk factors, including high Body Mass Index – Columbus ranked seventh highest nationwide – and obesity; Columbus ranked 12th highest nationwide.

"Hypertension can lead to a higher risk of serious health consequences like heart attack and stroke if left uncontrolled," said Sanjay Rajagopalan, M.D., a cardiologist and professor of internal medicine at The Ohio State University Medical Center. "The Hot Spots ranking reiterates hypertension's high prevalence in Columbus and reinforces the importance of patients working with their doctors to lower their blood pressure and reduce their risk for complications."

The Commit to Control exhibit will visit the Columbus 10TV Health & Fitness Expo on Aug. 20-21. To motivate residents to control their high blood pressure, the exhibit will offer free blood pressure screenings and the opportunity to see the effects hypertension can have on the body through an animated 3-D simulation. The tour schedule and additional resources on how patients can take steps toward managing their hypertension are available on Site visitors can also see a full list of the 50 Hypertension Hot Spots and make an online pledge to talk to their doctors about controlling hypertension. For each pledge made online, Takeda will donate $5, up to $10,000, to Mended Hearts, a community-based, nationwide heart patient support network.

About Hypertension

Hypertension, or high blood pressure, is a chronic medical condition in which the blood pressure is elevated. Blood pressure is the force of blood pushing against the walls of the arteries as the heart pumps out blood. Blood pressure numbers include systolic and diastolic pressures. Systolic pressure is the pressure exerted while the heart is beating. Diastolic blood pressure is the pressure when the heart is at rest. In blood pressure measurements, the systolic number appears above or before the diastolic number. Hypertension is defined as elevated blood pressure about 140 mm Hg or greater systolic or 90 mm Hg or greater diastolic. High blood pressure typically has no symptoms. In fact, of Americans who have hypertension, an estimated 20 percent are still unaware they have it. If left uncontrolled, hypertension can lead to serious health problems, including heart attack, stroke, kidney disease and congestive heart failure. Having high blood pressure can also shorten life expectancy by about five years, unless appropriately treated.

About the Hypertension Hot Spots Analysis

The analysis was conducted by Sperling's BestPlaces during the month of April 2011 for Takeda Pharmaceuticals North America, Inc. The goal of the study was to find the metropolitan areas in the United States that have hypertension risk factors and complications. To find these places in the United States, a large-scale analysis, which combined the findings of original research and existing, related research in the field of the study, was performed. The study compiled and analyzed data for the 50 largest U.S. metropolitan areas. To determine these Hypertension Hot Spots, Sperling's BestPlaces analyzed data about the following factors: self-reported diagnoses of hypertension, self-reported diagnoses of high cholesterol, self-reported diagnoses of cardiovascular disease, doctor diagnoses of hypertension (per capita), prescriptions of hypertension-control medication (per capita), mortality relating to hypertension, average Body Mass Index (BMI), obesity rate, smoking incidence and lack of exercise. The data came from the following sources: The Centers for Disease Control and Prevention (CDC) Behavioral Risk Factor Surveillance System, The CDC Wide-ranging Online Data for Epidemiologic Research (WONDER) database, The Gallup/Healthways Well-Being poll and ESRI data derived from the Doublebase Consumer Survey performed by Mediamark Research Inc. The analysis weighed the study's categories by assigning each a magnitude of importance based upon the focus of the study; some categories offered more insight into the prevalence of hypertension. All data was adjusted by the current population to arrive at "per capita" figures to provide an accurate comparison between cities of varying sizes.

About Bert Sperling

For more than twenty years, Bert Sperling has been helping people find their own Best Places to live, work, play and retire. As the foremost creator of these studies, his work appears in the national media nearly every month. Annually, his "Healthiest Cities for Women" study is featured in SELF magazine. Other health-related projects include "Migraine Hot Spots," "Asthma Hot Spots," "Best Cities for Sleep," "America's Healthiest Cities," "Best and Worst Cities for Skin Care" and "Most Visually Inspiring Places in America." Sperling's information is available on the website,

Takeda Pharmaceuticals North America, Inc., and Takeda Global Research & Development Center, Inc.

Based in Deerfield, Ill., Takeda Pharmaceuticals North America, Inc., and Takeda Global Research & Development Center, Inc. are subsidiaries of Takeda Pharmaceutical Company Limited, the largest pharmaceutical company in Japan. The respective companies currently market oral diabetes, insomnia, rheumatology, gastroenterology, and cardiovascular treatments and seek to bring innovative products to patients through a pipeline that includes compounds in development for metabolic and cardiovascular disease, gastroenterology, neurology and other conditions. To learn more about these Takeda companies, visit

Elissa J. Johnsen
Takeda Pharmaceuticals North America

Rebekah Sinzheimer

SOURCE Takeda Pharmaceuticals North America, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. PARIs eFlow Included in Gileads NDA Submission for Aztreonam Lysine for Inhalation
2. Agendias MammaPrint(R) Included in 2008 Dutch Institute for Healthcare Improvement CBO Guidelines
3. Agendias Breast Cancer Recurrence Test MammaPrint Included in International St. Gallen Expert Consensus Recommendations
4. Jiangbo Pharmaceuticals Osteomyelitis Treatment Tablets to be Included in Chinas National Insurance Directory
5. WuXi PharmaTech Included in the Deloitte Technology Fast 500 Asia Pacific 2009 List for the Sixth Consecutive Year
6. Chemosensitivity/Resistance Assay Included as Part of the NCCN Principles of Chemotherapy
7. Abbott Included on the Dow Jones Sustainability Indexes for Six Consecutive Years in Recognition of Leading Corporate Citizenship Performance
8. Wound Management Technologies Announces Secure eHealth Technology to be Included During HIMSS 2011 Interoperability Showcase
9. Additional 8 Products of DK Sinopharma, Inc. are Included in 2010 Provincial Medical Insurance Catalogs in 4 Separate Provinces in the Peoples Republic of China
10. OVA1 Included in Latest ACOG/SGO Committee Opinion
11. Lilly CEO Says Biopharmaceuticals Should Be Included in Transatlantic Trade and Economic Discussions
Post Your Comments:
(Date:11/26/2015)... , 26 november 2015 AAIPharma ... de geplande investering aan van ten minste ... laboratoria en het mondiale hoofdkantoor in ... zal resulteren in extra kantoorruimte en extra ... de groeiende behoeften van de farmaceutische en ...
(Date:11/26/2015)... November 26, 2015 --> ... use SyMRI to find optimal contrast weighting of MRI ... and has signed a research agreement with SyntheticMR in order ... Using SyMRI, it is possible to generate multiple contrast images ... the patient has left, thus making it possible to both ...
(Date:11/26/2015)... , Nov. 26, 2015 Research ... addition of the "2016 Future Horizons and ... (TDM) Market: Supplier Shares, Country Segment Forecasts, Competitive ... --> --> ... analysis of the Japanese therapeutic drug monitoring market, ...
Breaking Medicine Technology:
(Date:11/26/2015)... ... November 26, 2015 , ... CognisantMD and Cambridge ... imaging in the Waterloo region. Using the Ocean Platform, family physicians can now ... their electronic medical record (EMR) without the need for redundant patient entry or ...
(Date:11/26/2015)... ... 2015 , ... Jobs in hospital medical laboratories and in the imaging field ... agency Aureus Medical Group . These fields, as well as travel ... for healthcare jobs through the company’s website, , The leading healthcare ...
(Date:11/26/2015)... Viejo, CA (PRWEB) , ... November 26, 2015 ... ... users a new set of retro-fused, self-animating trailer titles with ProTrailer: Vintage. This ... style options. These classically-influenced trailer titles work with any font, giving users limitless ...
(Date:11/25/2015)... ... November 25, 2015 , ... Additional breast cancers ... on mammography, according to a study published online in the journal Radiology. Researchers ... mammography may necessitate a change in treatment. , Breast MRI is the most ...
(Date:11/25/2015)... ... November 25, 2015 , ... Finnleo, a leader in the traditional and far-infrared ... traditional and far-infrared saunas. , For traditional saunas, Finnleo is offering ... sauna wood, and Finnleo uses only European Grade A Nordic White Spruce from sustainably ...
Breaking Medicine News(10 mins):